Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors

由 Dromain, Clarisse, Pavel, Marianne E., Ruszniewski, Philippe, Langley, Alison, Massien, Christine, Baudin, Eric, Caplin, Martyn E.
發表在 BMC Cancer (2019)

Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3(rd)-line treatment

由 Lamarca, Angela, Cives, Mauro, de Mestier, Louis, Crona, Joakim, Spada, Francesca, Öberg, Kjell, Pavel, Marianne, Alonso-Gordoa, Teresa
發表在 World J Gastroenterol (2021)

Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3)

由 Apostolidis, Leonidas, Dal Buono, Arianna, Merola, Elettra, Jann, Henning, Jäger, Dirk, Wiedenmann, Bertram, Winkler, Eva Caroline, Pavel, Marianne
發表在 Cancers (Basel) (2021)

Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoids

由 Prasad, Vikas, Steffen, Ingo G., Pavel, Marianne, Denecke, Timm, Tischer, Elisabeth, Apostolopoulou, Konstantina, Pascher, Andreas, Arsenic, Ruza, Brenner, Winfried
發表在 EJNMMI Res (2015)

Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs

由 Singh, Simron, Granberg, Dan, Wolin, Edward, Warner, Richard, Sissons, Maia, Kolarova, Teodora, Goldstein, Grace, Pavel, Marianne, Öberg, Kjell, Leyden, John
發表在 J Glob Oncol (2016)

Effect of Lanreotide Depot/Autogel on Urinary 5‐Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors

由 Pavel, Marianne E., Phan, Alexandria T., Wolin, Edward M., Mirakhur, Beloo, Liyanage, Nilani, Pitman Lowenthal, Susan, Fisher, George A., Vinik, Aaron I.
發表在 Oncologist (2018)

Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study

由 Caplin, Martyn E., Pavel, Marianne, Phan, Alexandria T., Ćwikła, Jarosław B., Sedláčková, Eva, Thanh, Xuan-Mai Truong, Wolin, Edward M., Ruszniewski, Philippe
發表在 Endocrine (2020)

Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria

由 Rinke, Anja, Maintz, Christoph, Müller, Lothar, Weber, Matthias M., Lahner, Harald, Pavel, Marianne, Saeger, Wolfgang, Houchard, Aude, Ungewiss, Hanna, Petersenn, Stephan
發表在 Exp Clin Endocrinol Diabetes (2021)

Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate Cancer

由 Puranik, Ameya D, Dromain, Clarisse, Fleshner, Neil, Sathekge, Mike, Pavel, Marianne, Eberhardt, Nina, Zengerling, Friedemann, Marienfeld, Ralf, Grunert, Michael, Prasad, Vikas
發表在 Cancers (Basel) (2021)

Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome

由 Hudgens, Stacie, Ramage, John, Kulke, Matthew, Bergsland, Emily, Anthony, Lowell, Caplin, Martyn, Öberg, Kjell, Pavel, Marianne, Gable, Jonathon, Banks, Phillip, Yang, Qi Melissa, Lapuerta, Pablo
發表在 J Patient Rep Outcomes (2019)

Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis

由 Strosberg, Jonathan R, Yao, James C, Bajetta, Emilio, Aout, Mounir, Bakker, Bert, Hainsworth, John D, Ruszniewski, Philippe B, Van Cutsem, Eric, Öberg, Kjell, Pavel, Marianne E
發表在 Endocr Relat Cancer (2015)

Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors (pNET): Final Overall Survival (OS) Results of the RADIANT-3 Study

由 Pommier, Rodney, Pavel, Marianne, Lombard-Bohas, Catherine, Van Cutsem, Eric, Lam, Du, Kunz, Tiffany, Brandt, Ulrike, Capdevila, Jaume, De Vries, Elisabeth G.E., Tomassetti, Paola, Hobday, Timothy, Yao, James C.
發表在 Gastrointest Cancer Res (2014)

Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4

由 Buzzoni, Roberto, Carnaghi, Carlo, Strosberg, Jonathan, Fazio, Nicola, Singh, Simron, Herbst, Fabian, Ridolfi, Antonia, Pavel, Marianne E, Wolin, Edward M, Valle, Juan W, Oh, Do-Youn, Yao, James C, Pommier, Rodney
發表在 Onco Targets Ther (2017)

Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?

由 Bodei, Lisa, Bergsland, Emily, de Herder, Wouter W., Ferone, Diego, Hicks, Rodney J., Hope, Thomas A., Kunikowska, Jolanta, Pavel, Marianne, Reidy-Lagunes, Diane, Siveke, Jens, Strosberg, Jonathan, Dittmer, Ulf, Herrmann, Ken
發表在 J Nucl Med (2020)

Stage IV Gastro‐Entero‐Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome

由 Panzuto, Francesco, Merola, Elettra, Pavel, Marianne Ellen, Rinke, Anja, Kump, Patrizia, Partelli, Stefano, Rinzivillo, Maria, Rodriguez‐Laval, Victor, Pape, Ulrich Frank, Lipp, Rainer, Gress, Thomas, Wiedenmann, Bertram, Falconi, Massimo, Delle Fave, Gianfranco
發表在 Oncologist (2017)

Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment

由 Busse, Antonia, Mochmann, Liliana H., Spenke, Christiane, Arsenic, Ruza, Briest, Franziska, Jöhrens, Korinna, Lammert, Hedwig, Sipos, Bence, Kühl, Anja A., Wirtz, Ralph, Pavel, Marianne, Hummel, Michael, Kaemmerer, Daniel, Baum, Richard P., Grabowski, Patricia
發表在 Cancers (Basel) (2020)

Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study

由 Caplin, Martyn E, Pavel, Marianne, Ćwikła, Jarosław B, Phan, Alexandria T, Raderer, Markus, Sedláčková, Eva, Cadiot, Guillaume, Wolin, Edward M, Capdevila, Jaume, Wall, Lucy, Rindi, Guido, Langley, Alison, Martinez, Séverine, Gomez-Panzani, Edda, Ruszniewski, Philippe
發表在 Endocr Relat Cancer (2016)

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors

由 Kaltsas, Gregory, Caplin, Martyn, Davies, Philippa, Ferone, Diego, Garcia-Carbonero, Rocio, Grozinsky-Glasberg, Simona, Hörsch, Dieter, Tiensuu Janson, Eva, Kianmanesh, Reza, Kos-Kudla, Beata, Pavel, Marianne, Rinke, Anja, Falconi, Massimo, de Herder, Wouter W.
發表在 Neuroendocrinology (2017)

Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study

由 Yao, James C., Pavel, Marianne, Lombard-Bohas, Catherine, Van Cutsem, Eric, Voi, Maurizio, Brandt, Ulrike, He, Wei, Chen, David, Capdevila, Jaume, de Vries, Elisabeth G.E., Tomassetti, Paola, Hobday, Timothy, Pommier, Rodney, Öberg, Kjell
發表在 J Clin Oncol (2016)

Long‐Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome

由 Anthony, Lowell B., Kulke, Matthew H., Caplin, Martyn E., Bergsland, Emily, Öberg, Kjell, Pavel, Marianne, Hörsch, Dieter, Warner, Richard R.P., O'Dorisio, Thomas M., Dillon, Joseph S., Lapuerta, Pablo, Kassler‐Taub, Kenneth, Jiang, Wenjun
發表在 Oncologist (2019)